Educational references.
Review status stated on each guide.
Every article is editorial reference material. Independent physician review is pending unless the individual page expressly documents otherwise. Articles are not medical advice or evidence of an available WellSpry clinical service.
What Blood Tests Should You Get Before Starting GLP-1?
An educational outside-testing framework to discuss before semaglutide or tirzepatide; it is not the composition of a WellSpry panel.
GLP-1 Medicines and Body Composition
An educational overview of reported body-composition changes and questions for an independent clinician. It does not predict individual change or provide a prevention plan.
GLP-1 Nausea and Supplement Claims: Editorial Review in Progress
This prior article is unavailable while its medical, supplement, efficacy, dosing, and source claims undergo independent review.
GLP-1 Muscle-Loss Claims: Editorial Review in Progress
This prior article is unavailable while its medical, nutrition, exercise, supplement, dosing, and source claims undergo independent review.
Wegovy and Zepbound Claims: Editorial Review in Progress
This prior article is unavailable while its comparative treatment, efficacy, switching, monitoring, and source claims undergo independent review.
GLP-1 Side Effects and the Gut Microbiome
An educational overview of reported gastrointestinal symptoms, the limits of evolving microbiome evidence, and when to contact your own clinician.
The Gut Microbiome and GLP-1: Editorial Review in Progress
This prior article is unavailable while its medical, causal, treatment, supplement, dosing, and source claims undergo independent review.
Outside Testing to Discuss Before Starting GLP-1 Therapy
An educational outside-testing checklist to discuss before a first injection; it is not the composition of a WellSpry panel.
HOMA-IR Claims: Editorial Review in Progress
This prior article is unavailable while its diagnostic, predictive, treatment, dosing, and source claims undergo independent review.
Biological Age Testing Claims: Editorial Review in Progress
This prior article is unavailable while its medical, predictive, intervention, supplement, and source claims undergo independent review.
Peptide Compounding Regulation 2026: How to Read FDA Status
How to read FDA bulk-substance review without treating a category, nomination, or proposal as approval or availability.
BPC-157 Regulatory Status 2026: What FDA Review Does and Does Not Establish
BPC-157 is not FDA-approved. This dated overview explains FDA's 2026 review without treating a category, nomination, or proposal as lawful availability.
CJC-1295 and Ipamorelin: Editorial Review in Progress
This prior article is unavailable while its clinical, safety, efficacy, dosing, and regulatory claims undergo independent review.
Selank: Editorial Review in Progress
This prior article is unavailable while its clinical, safety, efficacy, dosing, and regulatory claims undergo independent review.
AOD-9604: Editorial Review in Progress
This prior article is unavailable while its clinical, safety, efficacy, dosing, and regulatory claims undergo independent review.
Thymosin Alpha-1: Editorial Review in Progress
This prior article is unavailable while its clinical, safety, efficacy, dosing, and regulatory claims undergo independent review.
Take the free quiz for an educational match to the published panel catalog. The result is not a treatment recommendation or eligibility decision.
Compare Published Panels →